Lista de obras - Patrick Pauwels - Dominio Público Uruguay

ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it

artículo científico publicado en 2014

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.

artículo científico publicado en 2013

Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination ⬇️

artículo científico publicado el 7 de septiembre de 2010

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity

artículo científico publicado en 2015

Cachexia in cancer: what is in the definition?

artículo científico publicado en 2016

Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.

artículo científico publicado en 2009

Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.

artículo científico publicado en 2017

Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays

artículo científico publicado en 2012

Current challenges for the advancement of neural stem cell biology and transplantation research.

artículo científico publicado en 2012

DFNA5 promoter methylation a marker for breast tumorigenesis

artículo científico publicado en 2017

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

artículo científico publicado en 2012

Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis

artículo científico publicado en 2010

Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas

artículo científico publicado en 2010

Exosomes as diagnostic and predictive biomarkers in lung cancer

artículo científico publicado en 2017

Exosomes genetic cargo in lung cancer: a truly Pandora's box

artículo científico publicado en 2016

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

artículo científico publicado en 2016

Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.

artículo científico publicado en 2008

Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma

artículo científico publicado en 2009

Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer

artículo científico publicado en 2013

Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma

artículo científico publicado en 2002

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

artículo científico publicado en 2002

Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.

scientific article published on 27 May 2011

Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect

artículo científico publicado en 2015

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

artículo científico publicado en 2014

Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.

artículo científico

Improvement in lung cancer outcomes with targeted therapies: an update for family physicians

artículo científico publicado en 2015

Intrapericardial cavernous hemangioma: an unusual mediastinal tumor!

scientific article published on 16 January 2019

Krüppel-like factors in cancer progression: three fingers on the steering wheel

artículo científico publicado en 2014

Liquid biopsies in lung cancer: the new ambrosia of researchers.

artículo científico publicado en 2014

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients.

artículo científico publicado en 2017

Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front

artículo científico publicado en 2008

Molecular profiling in lung cancer associated with cystic airspaces

artículo científico publicado en 2019

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response

artículo científico publicado en 2014

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

artículo científico publicado en 2016

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors.

artículo científico publicado en 2014

PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation

scientific article published on 04 December 2020

Postextubation obstructive pseudomembranes: a case series and review of a rare complication after endotracheal intubation.

artículo científico publicado en 2010

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.

artículo científico publicado en 2017

Prognostic role of vasculogenic mimicry in colorectal cancer.

artículo científico publicado en 2009

Proteomics in cancer research: Are we ready for clinical practice?

artículo científico

Recognition of cellular implants by the brain's innate immune system.

artículo científico publicado en 2010

Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions

scientific article published on 01 February 2020

Testing for ROS1 in non-small cell lung cancer: a review with recommendations

artículo científico publicado en 2016

The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment

artículo científico publicado en 2009

The interaction between ER and NFκB in resistance to endocrine therapy.

artículo científico publicado en 2012

The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein

artículo científico publicado en 2014

The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization

artículo científico publicado en 2014

The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target?

artículo científico publicado en 2014

Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia

artículo científico publicado en 2017

Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.

artículo científico publicado en 2005

Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.

artículo científico publicado en 2011

Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine.

artículo científico publicado en 2018

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer

artículo científico publicado en 2015

What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis

artículo científico

cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance

artículo científico

Lista de obras de Patrick Pauwels

ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.

Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination ⬇️

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity

Cachexia in cancer: what is in the definition?

Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.

Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.

Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays

Current challenges for the advancement of neural stem cell biology and transplantation research.

DFNA5 promoter methylation a marker for breast tumorigenesis

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis

Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas

Exosomes as diagnostic and predictive biomarkers in lung cancer

Exosomes genetic cargo in lung cancer: a truly Pandora's box

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.

Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma

Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer

Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.

Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.

Improvement in lung cancer outcomes with targeted therapies: an update for family physicians

Intrapericardial cavernous hemangioma: an unusual mediastinal tumor!

Krüppel-like factors in cancer progression: three fingers on the steering wheel

Liquid biopsies in lung cancer: the new ambrosia of researchers.

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients.

Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front

Molecular profiling in lung cancer associated with cystic airspaces

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors.

PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation

Postextubation obstructive pseudomembranes: a case series and review of a rare complication after endotracheal intubation.

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.

Prognostic role of vasculogenic mimicry in colorectal cancer.

Proteomics in cancer research: Are we ready for clinical practice?

Recognition of cellular implants by the brain's innate immune system.

Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions

Testing for ROS1 in non-small cell lung cancer: a review with recommendations

The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment

The interaction between ER and NFκB in resistance to endocrine therapy.

The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein

The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization

The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target?

Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia

Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.

Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.

Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine.

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer

What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis

cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance